Navigation Links
Geranylgeraniol suppresses the viability of human prostate cancer cells and HMG CoA reductase
Date:11/13/2013

Researchers at Texas Woman's University have shown that a diterpene geranylgeraniol found in linseed oil, Cedrela toona wood oil, sucupira branca fruit oil and more recently, annatto seed oil, suppressed the viability of human DU145 prostate carcinoma cells via cell cycle arrest at the G1 phase and the initiation of apoptosis. This finding, reported in the November 2013 issue of Experimental Biology and Medicine, supplies recent evidence supporting the tumor-suppressive potential of dietary isoprenoids, a class of phytochemicals encompassing ~55,000 mevalonate-derived secondary metabolites.

"This line of work dates back to the 1980s when the University of Wisconsin groups led by Drs. Charles Elson and Michael Gould discovered the anti-tumor activity of monoterpenes and soon after, sesqui- and di-terpenes." said Dr. Huanbiao Mo, senior author and professor in the Department of Nutrition and Food Sciences. These compounds, widely present in fruits, vegetables and grains, were found to be much more effective in suppressing the growth of tumor cells than that of normal cells. A study by Mo's group in a 2011 issue of Experimental Biology and Medicine (236:604-613) showed that normal fibroblasts are 10-fold more resistant than murine B16 melanoma cells to geranylgeraniol-mediated growth suppression. This tumor-targeted action of isoprenoids was manifested in animal studies showing no toxicity of isoprenoids at tumor-suppressive doses (reviewed by Mo & Elson, Exp Biol Med, 2004, 229:567-85). Previous work also suggested synergistic impact of isoprenoids on tumor growth, a finding remaining to be confirmed in prostate cancer.

In collaboration with the University of Texas Southwestern Medical Center (UTSW) in Dallas, the researchers found that the tumor-suppressive activity of geranylgeraniol was accompanied by down-regulation of HMG CoA reductase, a key enzyme in the mevalonate pathway that provides essential intermediates for the posttranslational modification of growth-related proteins such as Ras, nuclear lamins and insulin-like growth factor receptors. Isoprenoid-mediated suppression of HMG CoA reductase in tumors was previously correlated to growth arrest; the latter was attenuated by supplemental mevalonate. "This is the first time that geranylgeraniol was found to suppress HMG CoA reductase in prostate cancer cells," said Dr. Russell DeBose-Boyd, co-author and professor in the Department of Molecular Genetics and Howard Hughes Medical Institute at UTSW.

Other contributors are graduate students Nicolle Fernandes (now at Ball State University), Hoda Yeganehjoo, Rajasekhar Katuru (now at Baton Rouge General Medical Center), Lindsey Morris (UTSW), and Renee Michon and Dr. Zhi-Ling Yu of Hong Kong Baptist University.

Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine, said "This study by Huanbiao Mo and colleagues at the Texas Woman's University and UT Southwestern Medical Center demonstrates that geranylgeraniol causes dose dependent apoptotic death of human prostate carcinoma cells. They further show that this diterpine downregulates HMG CoA reductase offering support to the concept that mevalonate deprivation causes cell cycle arrest at the G1 phase leading to apoptotic death of the prostate carcinoma cells. Importantly this article suggests that geranylgeraniol deserves further study as a potential therapy for human prostate cancer."


'/>"/>

Contact: Huanbiao Mo
hmo@mail.twu.edu
Society for Experimental Biology and Medicine
Source:Eurekalert

Related medicine news :

1. PhenObestin 37.5 Suppresses Appetite as APA lists Binge-Eating as a Disorder
2. UNC researchers discover gene that suppresses herpesviruses
3. Key molecule suppresses growth of cancerous liver tumors, Mayo study finds
4. Lactation protein suppresses tumors and metastasis in breast cancer
5. Experimental Drug Suppresses Appetite in Mice: Study
6. Protect Cell Viability Outside the Incubator While Trypsinizing Cells During Cell Passaging with the Scienceware® CultureTemp™ 37°C Warming Plate by Bel-Art Products
7. Study: Methodology of determining financial viability of social security
8. Tel Aviv University part of team launching global Human Brain Project
9. Western University of Health Sciences’ Gala Fundraiser Emphasizes Humanism and Caring
10. Animal, human health benefits anticipated from universitys premier biomedical instrument
11. ENT and Allergy Associates, LLP® Adds Resources to Its Human Resources Department, Welcomes Eric M. Saidel, JD as Its New HR Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud ... and unique items from across the nation, this holiday-themed event will raise funds and ... the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based workplace ... Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored at ... from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
(Date:10/5/2017)... 5, 2017  In response to the nationwide ... Maxillofacial Surgeons (AAOMS) released prescribing recommendations that urge ... used as a first-line therapy to manage a ... Recognizing the value and importance ... "Opioid Prescribing: Acute and Postoperative Pain Management" stresses ...
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
Breaking Medicine Technology: